Search results for "Biochemistry"

showing 10 items of 20172 documents

The follow-up of dietary treatment of obesity

2008

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismBiochemistry (medical)OBESITY TREATMENT DIET SAFETY EFFICACYGeneral Medicinemedicine.diseaseObesityDietary treatmentInternal medicineDrug DiscoverymedicineImmunology and Allergybusiness
researchProduct

Do SLC7 Family Members Constitute the Salvage Pathway in the Therapy of Cystinosis?

2012

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismBioinformaticsmedicine.diseaseBiochemistrySurgeryEndocrinologyCystinosisGeneticsmedicinebusinessMolecular BiologyNucleotide salvageMolecular Genetics and Metabolism
researchProduct

Increase in left ventricular mass index and acroparesthesia incidence in children with Fabry disease correlates with their GLA mutation

2013

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismIncidence (epidemiology)medicine.diseaseBiochemistryFabry diseaseLeft ventricular massEndocrinologyInternal medicineMutation (genetic algorithm)GeneticsmedicineCardiologyAcroparesthesiabusinessMolecular BiologyMolecular Genetics and Metabolism
researchProduct

In vitro effects of oil's fatty acids on T cell function in gestational diabetic pregnant women and their newborns 油类脂肪酸在体外对妊娠期糖尿病孕妇及其新生儿的T细胞功能的影响

2014

Background The aim of this investigation was to determine the in vitro effects of linseed, olive and Nigel oils on T cell proliferation and function in gestational diabetes. Methods Blood samples were collected from 40 control healthy and 32 gestational diabetic mothers and their newborns. Peripheral blood lymphocytes were isolated using a density gradient of Ficoll. T cell proliferation, interleukin-2 and -4 (IL-2, IL-4) secretion, fatty acid composition and intracellular oxidative status were investigated. Results Mitogen (Concanavalin A) stimulated lymphocyte proliferation, IL-2 secretion, intracellular reduced glutathione levels, superoxide dismutase (SOD) and catalase activities were l…

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismT cellmedicine.diseaseIn vitromedicine.anatomical_structureEndocrinologyBiochemistryInternal medicineDiabetes mellitusmedicineGestationbusinessFunction (biology)Journal of Diabetes
researchProduct

T-cell cloning in human type I diabetes.

1992

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismT-LymphocytesT lymphocyteHuman typemedicine.disease_causemedicine.diseaseBiochemistryAutoimmunityT cell cloningClone CellsEndocrinologyEndocrinologyDiabetes Mellitus Type 1Diabetes mellitusInternal medicineInsulin dependent diabetesImmunologymedicineHumansbusinessDiabetes/metabolism reviews
researchProduct

Enzyme replacement therapy in Fabry disease: Comparison of agalsidase alfa and agalsidase beta

2008

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismUrologyEnzyme replacement therapymedicine.diseaseBiochemistryFabry diseaseAGALSIDASE BETAEndocrinologyGeneticsmedicinebusinessMolecular BiologyAgalsidase alfaMolecular Genetics and Metabolism
researchProduct

Risk Factors for Secondary Cancer in a Case-Control Study on 1,259 Patients with Myeloproliferative Neoplasms

2018

Abstract INTRODUCTION The incidence of secondary cancer (SC) in patients with myeloproliferative neoplasms (MPN) is high and comparable to that of thrombosis. However, the identification of patient subgroups that might be at increased susceptibility of developing SC has not been systematically addressed. We report here the results of an international case-control study (MPN-K) aimed at comparing the frequency of exposure to possible causes of SC in patients with classical MPN, polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF). METHODS This European Leukaemia Network (ELN) study reports MPN patients from 28 sites of 5 European countries and Israel, diagnosed in th…

medicine.medical_specialtybusiness.industryEssential thrombocythemiaPipobromanIncidence (epidemiology)ImmunologyCase-control studyCancerCell BiologyHematologymedicine.disease030226 pharmacology & pharmacyBiochemistryGastroenterology03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicineMedicineRisk factorSkin cancerbusinessMyelofibrosismedicine.drugBlood
researchProduct

Preface: Approaches of Chinese Medicine to Oncology

2011

medicine.medical_specialtybusiness.industryFamily medicineGeneticsmedicineMolecular MedicineTraditional Chinese medicinebusinessBiochemistryBiotechnologyForum on Immunopathological Diseases and Therapeutics
researchProduct

Clinical utility and physician perceptions of a digital platform for electronic patient-reported outcomes monitoring in patients with hematologic mal…

2021

Abstract Background There is now great interest in using digital health tools to monitor patients' health status in real-world practice. Such tools often include electronic-patient-reported outcome (ePRO) systems in which symptoms questions are included into online interfaces for patient self-reporting, with real-time alerts triggered to the treating physician if severe symptoms or problems are reported. However, there is little information about the clinical utility and user perceptions of these systems, and this is particularly true in the area of hematology. Objectives This study investigates physicians' perceptions of usability and clinical utility of using remote ePROs in routine pract…

medicine.medical_specialtybusiness.industryFamily medicineImmunologyPhysician perceptionMedicineIn patientCell BiologyHematologybusinessBiochemistry
researchProduct

45th meeting of the Arbeitsgemeinschaft Dermatologische Forschung

2018

medicine.medical_specialtybusiness.industryFamily medicineMEDLINEMedicineDermatologybusinessMolecular BiologyBiochemistryExperimental Dermatology
researchProduct